← Back to all trials
Not Yet Recruiting
NCT07691996
Effects of Melatonin on Sleep Architecture of Critically Ill Patients in the ICU
Conditions: Critical Illness, ICU, ICU Hospitalization, Melatonin, Sleep
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 30
Sponsor: Rutgers, The State University of New Jersey
Summary
This is a pilot study to examine the effects of melatonin on the sleep patterns of critically ill patients. Patients will have their sleep patterns measured with a device attached to their head with a headband then be given a dose of melatonin. Their participation in the study will last two days.
Eligibility Criteria
Inclusion Criteria:
18 years or older, admitted to the ICU Expected length of stay of at least 48 hours Not mechanically ventilated Able to take oral medications. Hemodynamically stable as determined by the treating ICU physician Able to provide informed consent or have consent provided by a legally authorized representative.
Exclusion Criteria:
Mechanically ventilated Currently using melatonin prior to ICU admission, Have neurological conditions that may significantly alter sleep architecture, such as traumatic brain injury, stroke, or severe dementia.
Pregnant or lactating individuals Those individuals with a comfort measures-only status
Source: ClinicalTrials.gov (NCT07691996). StuddyBuddy aggregates publicly available trial information.
